Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지

Type 2 diabetes mellitus and metabolic syndrome

2형 당뇨병 및 대사증후군

  • Hwang, Jin Soon (Department of Pediatrics, Ajou University School of Medicine)
  • 황진순 (아주대학교 의과대학 소아과학교실)
  • Received : 2006.05.08
  • Accepted : 2006.05.14
  • Published : 2006.07.15
Download PDF
⟨ Previous Next ⟩

Abstract

Type 2 diabetes mellitus in children and adolescents has been increasing for last 10 years. The increase in frequency of type 2 diabetes appears to parallel the increase in prevalence and severity of obesity in children and adolescents. The metabolic syndrome, cluster of potent risk factors for atherosclerotic cardiovascular disease and type 2 diabetes, consists of insulin resistance, obesity, hypertension and hyperlipidemia. The atherosclerotic cardiovascular disease are rarely seen in the young, but the pathologic processes and risk factors are associated its development have been shown to begin during childhood. In pediatrician it is important to recognize early and treat aggressively for prevention of future cardiovascular disease in children and adolescents with metabolic syndrome.

Keywords

References

  1. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607 https://doi.org/10.2337/diabetes.37.12.1595
  2. Falkner B, Hassink S, Ross J, Gidding S. Dysmetabolic syndrome : multiple risk factors for premature adult disease in an adolescent girl. Pediatrics 2002;110:e1-5 https://doi.org/10.1542/peds.110.1.1
  3. American Diabetes Association. Type 2 diabetes in children and adolescents. Pediatrics 2000;105:671-80 https://doi.org/10.1542/peds.105.3.671
  4. Goran MI, Ball GDC, Cruz ML. Cardiovascular endocrinology 2; obesity and risk of type 2 diabetes and cardiovascular disease in children and adolescents. J Clin Endocrinol Metab 2003;88:1417-27 https://doi.org/10.1210/jc.2002-021442
  5. Kaufman FR. Type 2 diabetes mellitus in children and youth : a new epidemic. J Pediatr Endocrinol Metab 2002; 15:737-44
  6. Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 2001;345:790-7 https://doi.org/10.1056/NEJMoa010492
  7. Ronnemaa T, Koskenvuo M, Marniemi J, Kolvunen T, Sajantila A, Rissanen A, et al. Glucose metabolism in identical twins discordant for obesity : the critical role of visceral fat. J Clin Endocrinol Metab 1997;82:383-7 https://doi.org/10.1210/jc.82.2.383
  8. Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002;346:802-10 https://doi.org/10.1056/NEJMoa012578
  9. Fagot-Campagna A, Pettitt DJ, Engelgau MM, Burrows NR, Geiss LS, Valdez R, et al. Type 2 diabetes among North American children and adolescents; an epidemiologic review and a public health perspective. J Pediatr 2000;136: 664-72 https://doi.org/10.1067/mpd.2000.105141
  10. Hollander P. The case for tight control in diabetes. Postgrad Med 1984;75:80-7 https://doi.org/10.1080/00325481.1984.11697954
  11. McGill H, McMahan CA, Deteminants of atherosclerosis in the young; pathobiological determinants of atherosclerosis in youth(PDAY) research group. Am J Cardiol 1998;82: 30T-6T
  12. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993: 329:977-86 https://doi.org/10.1056/NEJM199309303291401
  13. American Diabetes Association. Type 2 diabetes in children and adolescents. Diabetes Care 2000;23:381-9 https://doi.org/10.2337/diacare.23.3.381
  14. Srinivasan SR, Frontoni MG, Berenson GS. Longitudinal changes in risk variables of insulin resistance syndrome from childhood to young adulthood in offspring of parents with type 2 diabetes; the Bogalusa Heart Study. Metabolism 2003;52-443-50 https://doi.org/10.1053/meta.2003.50065
  15. Pinhas-Hamiel O, Dolan LM, Daniels SR, Standiford D, Khoury PR, Zeitler P. Increased incidence of non-insulin dependent diabetes mellitus among adolescents. J Pediatr 1996;128:608-15 https://doi.org/10.1016/S0022-3476(96)80124-7
  16. Scott C, Smith J, Cradock M, Pihoker C. Characteristics of youth-onset non-insulin dependent diabetes mellitus and insulin-dependent diabetes mellitus at diagnosis. Pediatrics 1997;100:84-91 https://doi.org/10.1542/peds.100.1.84
  17. Fagot-Campagna A, Knowler WC, Pettitt DJ. Type 2 diabetes in Pima Indian children : cardiovascular risk factors at diagnosis and 10 years later [abstract]. Diabetes 1998;47 (Suppl l):A155 https://doi.org/10.2337/diab.47.2.155
  18. Yokoyama H, Okudaira M, Otani T, Watanabe C, Takaike H, Miura J, et al. High incidence of diabetic nephropathy in earlyonset Japanese NIDDM patients : risk analysis. Diabetes Care 1998;21:1080-5 https://doi.org/10.2337/diacare.21.7.1080
  19. Yokoyama H, Okudaira M, Otani T, Takaike H, Miura J, Saeki A, et al. Existence of early-onset NIDDM Japanese demonstrating severe diabetic complications. Diabetes Care 1997;20:844-7 https://doi.org/10.2337/diacare.20.5.844
  20. Meigs JB. Epidemiology of cardiovascular complications in type 2 diabetes mellitus. Acta Diabetol 2003;40(Suppl 2): S358-61 https://doi.org/10.1007/s00592-003-0120-0
  21. Zieske AW, Malcom GT, Strong JP. Natural history and risk factors of atherosclerosis in children and youth : the PDAY study. Pediatr Pathol Mol 2002;21:213-37 https://doi.org/10.1080/15227950252852104
  22. Berenson GS. Childhood risk factors predict adult risk associated with subclinical cardiovascular disease : the Bogalusa Heart Study. Am J Cardiol 2002;90:3L-7L https://doi.org/10.1016/S0002-9149(02)02953-3
  23. Gungor N, Bacha F, Saad R, Janosky J, Arslanian S, et al. Youth type 2 diabetes : insulin resistance, beta-cell failure, or both? Diabetes Care 2005;28:638-44 https://doi.org/10.2337/diacare.28.3.638
  24. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344: 1343-50 https://doi.org/10.1056/NEJM200105033441801
  25. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403 https://doi.org/10.1056/NEJMoa012512
  26. Matthews DR, Cull CA, Stratton IM, Holman RR, Turner RC, et al. UKPDS 26 : sulfonylurea failure in non-insulin dependent diabetic patients over six years. Diabet Med 1998;15:297-303 https://doi.org/10.1002/(SICI)1096-9136(199804)15:4<297::AID-DIA572>3.0.CO;2-W
  27. Gungor N, Arslanian S. Progressive beta cell failure in type 2 diabetes mellitus of youth. J Pediatr 2004;144:656-9 https://doi.org/10.1016/j.jpeds.2003.12.045
  28. Glaser B, Cerasi E. Early intensive insulin treatment for induction of long-term glycaemic control in type 2 diabetes. Diabetes Obes Metab 1999;1:67-74 https://doi.org/10.1046/j.1463-1326.1999.00015.x
  29. Jones KL, Arslanian S, Peterokova VA, Park JS, Tomlinson MJ, et al. Effect of metformin in pediatric patients with type 2 diabetes : a randomized controlled trial. Diabetes Care 2005;25:89-94 https://doi.org/10.5333/KGFS.2005.25.2.089
  30. Rosenbloom Al, Joe JR, Young RS, Winter WE, et al. Emerging epidemic of type 2 diabetes in youth. Diabetes Care 1999;22:345-54 https://doi.org/10.2337/diacare.22.2.345
  31. Defronzo RA. Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med 2000;133:73-4 https://doi.org/10.7326/0003-4819-133-1-200007040-00016
  32. Kavey RE, Daniels SR, Lauer RM, Atkins DL, Hayman LL, Taubert K, et al. American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. J Pediatr 2003;142: 368-72 https://doi.org/10.1067/mpd.2003.205
  33. Khaw KT, Wareham N, Luben R, Bingham S, Oakes S, Welch A, et al. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European prospective investigation of cancer and nutrition(EPIC-Norfolk). BMJ 2001;322:15-8 https://doi.org/10.1136/bmj.322.7277.15
  34. American Diabetes Association. Management of dyslipidemia in children and adolescents with diabetes. Diabetes Cared 2003;26:2194-7 https://doi.org/10.2337/diacare.26.7.2194
  35. Despres JP. The insulin resistance-dyslipidemia syndrome : the most prevalent cause of coronary artery disease- Can Med Assoc J 1993;148:1339-40
  36. Haffner SM, Valdez RA, Hazuda HP, Michell BD, Morales PA, Stern MP. Prospective analysis of the insulin resistance syndrome(syndrome x). Diabetes 1992;41:715-22 https://doi.org/10.2337/diabetes.41.6.715
  37. Berenson GS, Srinivasan SR, Bao W, Newman WP, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. N Engl J Med 1998;338:1650-6 https://doi.org/10.1056/NEJM199806043382302
  38. Cook S, Weitzman M, Auinger MS, Nguyen M, Dietz WH. Prevalence of metabolic syndrome phenotype in adolescents. Arch Pediatr Adolesc Med 2003;157:821-7 https://doi.org/10.1001/archpedi.157.8.821
  39. Bitsori M, Kafatos A. Dysmetaolic syndrome in childhood and adolescence. Acta Paediatr 2005;94:995-1005 https://doi.org/10.1080/08035250510029532
  40. Csabi G, Torok K, Jeges S, Molnar D. Presence of metabolic cardiovascular syndrome in obese children. Eur J Pediatr 2000;159:91-7 https://doi.org/10.1007/PL00013812
  41. Chen W, Srinivasan SR, Elkasabany A, Berenson GS. Cardiovascular risk factors clustering features of insulin resistance syndrome(syndrome X) in a biracial(black-white) population of children, adolescents, and young adults : the Bogalusa Heart Study. Am J Epidemiol 1999;150:667-74 https://doi.org/10.1093/oxfordjournals.aje.a010069
  42. Bacha F, Saad R, Gungor N, Janosky J, Arslanian SA. Obesity, regional fat distribution, and syndrome X in obese black versus white adolescents : race differential in diabetogenic and atherogenic risk factors. J Clin Endocrinol Metab 2003;88:233-40
  43. Liese AD, Mayer-Davis EJ, Haffner SM. Development of the multiple metabolic syndrome : an epidemiologic perspective. Epidemiol Rev 1998;20:157-72 https://doi.org/10.1093/oxfordjournals.epirev.a017978
  44. Odeleye OE, de Courten M, Pettitt DJ, Ravussin E. Fastion hyperinsulinemia is a predictor of increased body weight gain and obesity in pima Indian children. Diabetes 1997; 46:1311-45
  45. Ogden Cl, Flegal KM, Caroll MD, Johnson CL. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 2002;288:1728-32 https://doi.org/10.1001/jama.288.14.1728
  46. Martin BC, Warram JH, Rosner B, Rich SS, Soeldner JS, Krolewski AS. Familial clustering of insulin sensitivity. Diabetes 1992;41:850-4 https://doi.org/10.2337/diabetes.41.7.850
  47. Mayer EJ, Newman B, Austin Ma, Zhang D, Quesenberry CP Jr, Edwards K, et al. Genetic and environmental influences on insulin levels and the insulin resistance syndrome : an analysis of women twins. Am J Epidemiol 1996; 143:323-32 https://doi.org/10.1093/oxfordjournals.aje.a008746
  48. Whitaker RC, Wright JA, Pepe MS, Seidel KD, Dietz WH. Predicting obesity in young adulthood from childhood and parental obesity. N Engl J Med 1997;337:869-73 https://doi.org/10.1056/NEJM199709253371301
  49. Bao W, Srinivasan SR, Valdez R, Greenlund KJ, Wattigney WA, Berenson GS. Longitudinal changes in cardiovascular risk from childhood to young adulthood in offspring of parents with coronary artery disease : the Bogalusa Heart Study. JAMA 1997;278:1749-54 https://doi.org/10.1001/jama.278.21.1749
  50. Berenson GS, Bao W, Srinivasan SR. Abnormal characteristics in young offspring of parents with non-insulindependent diabetes mellitus. The Bogalusa Heart Study. Am J Epidemiol 1996;144:962-7 https://doi.org/10.1093/oxfordjournals.aje.a008866
  51. Stinivasan SR, Elkasabani A, Dalferes ER Jr, Bao W, Berenson GS. Characteristics of young offspring of type 2 diabetic parents in a biracial(black-white) community-based sample : the Bogalusa Heart Study. Metabolism 1998;47: 998-1004 https://doi.org/10.1016/S0026-0495(98)90358-4
  52. Ng MC, So WY, Lam VK, Cockram CS, Bell GI, Cox NJ, et al. Genome-wide scan for metabolic syndrome and related quantitative traits in Hong Kong Chinese and confirmation of a susceptibility locus on chromosome 1q21- q25. Diabetes 2004;53:2676-83 https://doi.org/10.2337/diabetes.53.10.2676
  53. Hales CN, Barker Dj, Clark PM, Cox LJ, Fall C, Osmond C, et al. Fetal and infant growth and impaired glucose tolerance at age 64. Br Med J 1991;303:1019-22 https://doi.org/10.1136/bmj.303.6809.1019
  54. Hattersley AT, Tooke JE. The fetal insulin hypothesis : an alternative explanation of the association of low birth weight with diabetes and cardiovascular disease. Lancet 2002;359:46-7 https://doi.org/10.1016/S0140-6736(02)07281-1
  55. Barker DJP, Gluckman PD, Godrey KM, Harding J, Owens JA, Robinson JS. Fetal nutrition and cardiovascular disease. Lancet 1993;341:938-41 https://doi.org/10.1016/0140-6736(93)91224-A
  56. Chatelain P. Children born with intra-uterine growth retardation( IUGR) or small for gestational age(SGA) : long term growth and metabolic consequences. Endocr Regul 2000; 34:33-6
  57. Kishida K, Nagaretani H, Kondo H, Kobayashi H, Tanaka S, Maeda N, et al. Disturbed secretion of mutant adiponectin associated with the metabolic syndrome. Biochem Biophys Res Commun 2003;306:286-92 https://doi.org/10.1016/S0006-291X(03)00940-9
  58. McTerman Cl, McTerman PG, Harte AL, Levick PL, Barnett A, Kumar S. Resistin, central obesity, and type 2 diabetes. Lancet 2002;359:46-7 https://doi.org/10.1016/S0140-6736(02)07281-1
  59. Das UN. Obesity, metabolic syndrome X, and inflammation. Nutrition 2002;18:430-2 https://doi.org/10.1016/S0899-9007(01)00747-X
  60. Din JN, Newby DE, Flapan AD. Omega 3 fatty acids and cardiovascular disease-fishing for a natural treatment. Br Med J 2004;328:30-5 https://doi.org/10.1136/bmj.328.7430.30
  61. Guo SS, Wu W, Chumlea WC, Roche AF. Predicting overweight and obesity in adulthood from body mass index values in childhood and adolescence. Am J Clin Nutr 2002; 76:653-8 https://doi.org/10.1093/ajcn/76.3.653
  62. Gil-Campos M, Canete RR, Gil A. Adiponectin, the missing link in insulin resistance and obesity. Clin Nutr 2004;23: 963-74 https://doi.org/10.1016/j.clnu.2004.04.010
  63. Reaven GM, Lithell H, Landberg L. Hypertension and associated metabolic abnormalities-the role of insulin resistance and the sympathoadrenal system. New Engl J Med 1996; 334:374-81 https://doi.org/10.1056/NEJM199602083340607
  64. Webber LS, Srinivasan SR, Wattigney WA, Berenson GS. Tracking of serum lipids and lipoproteins from childhood to adulthood. The Bogalusa Heart Study. Am J Epidemiol 1991;133:884-99 https://doi.org/10.1093/oxfordjournals.aje.a115968
  65. Vanhala M, Vanhala P, Kumpusalo E, Halonen P, Takala J. Relation between obesity from childhood to adulthood and the metabolic syndrome: population based study. Br Med J 1998;317:319 https://doi.org/10.1136/bmj.317.7154.319
  66. Srinivasan SR, Myers L, Berenson GS. Predictability of childhood adiposity and insulin for developing insulin resistance syndrome(syndrome X) in young adulthood. The Bogalusa Heart Study. Diabetes 2002;51:204-9 https://doi.org/10.2337/diabetes.51.1.204
  67. Morales PA, Mitchell BD, Valdez RA, Hazuda HP, Stern MP, Haffner SM. Incidence of NIDDM and impaired glucose tolerance in hypertensive subjects. The San Antonio Heart Study. Diabetes 1993;42:154-61 https://doi.org/10.2337/diabetes.42.1.154
  68. Travers SH, Jeffers BW, Bloch CA, Hill JO, Eckel RH. Gender and Tanner stage differences in body composition and insulin sensitivity in early pubertal children. J Clin Endocrinol Metab 1995;80:172-8 https://doi.org/10.1210/jc.80.1.172
  69. Steinberger J, Moorehead C, Katch V, Rocchini AP. Relationship between insulin resistance and abnormal lipid profile in obese adolescents. J Pediatr 1995;126:690-5 https://doi.org/10.1016/S0022-3476(95)70394-2
  70. Steinberger J, Daniels SR. Obesity, Insulin resistance, diabetes, and cardiovascular risk in children : an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee( Council on Cardiovascular Disease in the Young) and the Diabetes Committee(Council on Nutrition, Physical Activity, and Metabolism). Circulation 2003;107:1448-53 https://doi.org/10.1161/01.CIR.0000060923.07573.F2
  71. Valente AM, Strong W, Sinaiko A. Obesity and insulin resistance in young people. Am Heart J 2001;142:440-4 https://doi.org/10.1067/mhj.2001.117828
  72. Yngve A, Sjostrom M. Breastfeeding in countries of the European Union and EFTA : current and proposed recommendations, rationale, prevalence, duration and trends. Public Health Nutr 2001;4:631-45
  73. Krebs NF, Jacobson MS, American Academy of Pediatrics Committee on Nutrition. Prevention of pediatric overweight and obesity. Pediatrics 2003;112:424-30 https://doi.org/10.1542/peds.112.2.424
  74. Robinson T. Reducing children's television viewing to prevent obesity : a randomised controlled trial. JAMA 1999;282: 1561-7 https://doi.org/10.1001/jama.282.16.1561
  75. Maki KC. Dietary factors in the prevention of diabetes mellitus and coronary artery disease associated with the metabolic syndrome. Am J Cardiol 2004;S93:12-7
  76. Hardin DS, Hebert JD, Bayden T, Dehart M, Mazur L. Treatment of childhood syndrome X. Pediatrics 1997;100:e5
  77. Sondike SB, Copperman N, Jacobson MS. Effects of a low-carbohydrate diet on weight loss and cardiovascular risk factor in overweight adolescents. J Pediatr 2003;142: 253-8 https://doi.org/10.1067/mpd.2003.4
  78. Epstein LH, Wing RR, Penner BC, Kress MJ. Effect of diet and controlled exercise on weight loss in obese children. J Pediatr 1985;107:358-61 https://doi.org/10.1016/S0022-3476(85)80506-0
  79. Raustrop A, Pangrazi RP, Stahle A. Physical activity level and body mass index among schoolchildren in south-eastern Sweden. Acta Paediatr 2004;93:400-4 https://doi.org/10.1080/08035250310007484
  80. Harrell JS, Gansky SA, McMurray RG, Bungdiwala SI, Frauman AC, Bradley CB. School-based interventions improve health in children with multiple cardiovascular risk factors. Pediatrics 1998;102:371-80 https://doi.org/10.1542/peds.102.2.371
  81. Freemark M, Bursey D. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes. Pediatrics 2001;107:e55 https://doi.org/10.1542/peds.107.4.e55
  82. Kay JP, Alemzadeh R, Langley G, D'Angelo L, Smith P, Holshouser S. Beneficial effects of metformin in normoglycemic morbidly obese adolescents. Metabolism 2001;50: 1457-61 https://doi.org/10.1053/meta.2001.28078